NASH Drug Pipeline Shows Promise
Analysts have forecasted the market for NASH drugs could reach $20 billion by 2025.
Study Suggests Digestive Symptoms May Be Associated with COVID-19
A recent study from China found that diarrhea was a prominent symptom among up to half of patients with COVID-19 during the outbreak in Wuhan.
COVID-19 May Remain Detectable on Surfaces, in Aerosols for Several Hours
A study evaluated the stability of COVID-19 compared with SARS-CoV-1.
Ubrogepant: A Novel Drug Mechanism for Migraine Treatment
On December 23, 2019, the FDA approved ubrogepant for the acute treatment of migraine with and without aura in adult patients.
Clinical Trials of Sarilumab to Treat Severe COVID-19 Set to Begin in the US
Sarilumab is currently used to treat adult patients with moderately-to-severely active rheumatoid arthritis after treatment with at least 1 disease-modifying antirheumatic drug.
Clinical Trial Launched for Investigational COVID-19 Vaccine
A clinical trial evaluating an investigational vaccine for the 2019 novel coronavirus, SARS-CoV-2, has been launched, with volunteers receiving the first injection on March 16.
What Pharmacists Should Know About Multiple Sclerosis
Approximately 1 million individuals are living with multiple sclerosis in the United States, according to the National MS Society.
New Study Examines Why Some Fare Better with the Flu Than Others
A new study examines why some individuals are able to fight off the flu better than others. The answer, in part, may lead back to childhood.
EHR Data Analysis Suggests Need for Improvement in Blood Pressure Management
A new study found several shortcomings in blood pressure management.
CROI 2020: New Data Comparing Descovy, Truvada for HIV PrEP
At the 2020 Conference on Retroviruses and Opportunistic Infections (CROI), longer-term study results on emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets (Descovy, Gilead) for HIV PrEP were presented.
Report Shows Newer DAA Therapy Highly Effective for HCV, Recommends Universal Screening
A new systematic review demonstrates efficacy of direct-acting antiviral therapies and supports a recommendation for universal screening of hepatitis C virus.
Investigational Drug May Reduce Symptoms in Refractory GERD
A new study tested the investigational drug in combination with proton pump inhibitors for patients with gastroesophageal reflux disease.
Benefits of Hypertension Treatments Largely Similar Across Drug Classes
The differences between antihypertension medication classes were generally small and nuanced in terms of their effect on reducing cardiovascular risks.
Analysis: Apixaban Associated with Lower Risks Than Warfarin
A secondary analysis presented at the American Stroke Association’s International Stroke Conference 2020 confirmed the safety of apixaban treatment.
FDA Approves First IV Treatment for Migraine Prevention
Eptinezumab-jjmr (Vyepti, Lundbeck) decreased mean monthly migraine days in adult patients in 2 phase 3 clinical trials.
Patients At Highest Risk of Overdose at Beginning, After End of Methadone Treatment
Patients receiving methadone treatment are at most risk of overdosing during the first 4 weeks of treatment initiation and following the end of treatment.
Express Scripts Report: Top Drug Classes Driving Spending Growth
Express Scripts’ annual Drug Trend Report highlights top contributors to prescription drug spending in 2019.
Real-World Data Show Clinical Benefits of FreeStyle Libre System in Diabetes
The FreeStyle Libre system decreased HbA1c, increased time in glucose range, and reduced diabetes complications.
New Options for Sickle Cell Disease
Despite sickle cell disease's (SCD) lower profile, 3 new SCD drugs were approved in the last 3 years, with 2 approvals occurring in late 2019
Adolescents, Young Adults with HIV Have Lower Viral Suppression Rates
Quicker referral time to youth-friendly care services could help younger patients with HIV achieve better outcomes.
Pharmacists Play An Essential Role In A Diabetes Care Team
The pharmacist’s role in diabetes management is more important than ever before, given the number of patients with diabetes and the number of options available for treating them.
Half of Pregnant Women With HIV Not Prescribed Recommended Antiretroviral Therapy
The study evaluated whether antiretroviral therapy prescribing practices reflected current national guidelines.
Conquering Cancer Pain
Special consideration for pain management in patients with cancer.
Massachusetts Hospital Uses Telehealth to Increase Access to Opioid Treatment
A UMass Memorial telehealth-based program connects patients with credentialed clinicians who can prescribe medication-assisted treatment for opioid use disorder.
Study Adds to Evidence Linking Rosiglitazone to Cardiovascular Risks
Rosiglitazone, which is used to treat type 2 diabetes, may increase the risk of heart problems.
Optimizing Outcomes for High-Risk Patients
Med Sync, collaborative care, and compensation for clinical services.
What Pharmacists Should Know About Trends in IBD Treatment
Pharmacists can play an integral role in managing patients with inflammatory bowel disease (IBD) through medication management.
Is Shingles Contagious?
Shingles is not contagious; however, the potential for exposing a person to another viral infection that leads to shingles is very real.
Coronavirus News Roundup: Mask Shortages, Drug Development, and FDA Response
The latest in how consumers are reacting to the new coronavirus, how it’s impacting pharmacies, and response efforts.
Treatment with Risdiplam Improves Motor Function in Spinal Muscular Atrophy
Genentech announced new 1-year data from the SUNFISH trial evaluating risdiplam in spinal muscular atrophy.